POETA, ELEONORA

POETA, ELEONORA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

Assegnisti  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.018 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth Vaaland Holmgard I.C.; Gonzalez-Bakker A.; Poeta E.; Puerta A.; Fernandes M.X.; Monti B.; Fernand...ez-Bolanos J.G.; Padron J.M.; Lopez I.; Lindback E. 2024-01-01 ORGANIC & BIOMOLECULAR CHEMISTRY - 1.01 Articolo in rivista -
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease Santini A.; Tassinari E.; Poeta E.; Loi M.; Ciani E.; Trazzi S.; Piccarducci R.; Daniele S.; Mart...ini C.; Pagliarani B.; Tarozzi A.; Bersani M.; Spyrakis F.; Danková D.; Olsen C.A.; Soldati R.; Tumiatti V.; Montanari S.; De Simone A.; Milelli A. 2024-01-01 ACS CHEMICAL NEUROSCIENCE - 1.01 Articolo in rivista acs-cn.pdf
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer Guardigni M.; Greco G.; Poeta E.; Santini A.; Tassinari E.; Bergamini C.; Zalambani C.; De Simone... A.; Andrisano V.; Uliassi E.; Monti B.; Bolognesi M.L.; Fimognari C.; Milelli A. 2024-01-01 RSC MEDICINAL CHEMISTRY - 1.01 Articolo in rivista d4md00175c.pdfd4md00175c1.pdf
Metabolic supplementations and epigenetic alterations in in vitro AGC1 deficiency models Giorgia Babini, Eleonora Poeta, Francesca Massenzio, Federico Manuel Giorgi, Laura Mercolini, Ma...ssimo Lasorsa, Barbara Monti 2024-01-01 - - 4.02 Riassunto (Abstract) -
Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs) Nicola Balboni, Giorgia Babini, Eleonora Poeta, Michele Protti, Laura Mercolini, Maria Chiara Mag...nifico, Simona Nicole Barile, Francesca Massenzio, Antonella Pignataro, Federico M Giorgi, Francesco Massimo Lasorsa, Barbara Monti 2024-01-01 CELLULAR AND MOLECULAR BIOLOGY LETTERS - 1.01 Articolo in rivista s11658-024-00563-z.pdf
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation Francesca De Chirico, Francesca Massenzio, Eleonora Poeta, Giorgia Babini, Sabrina Petralla, Ma...non Elise Libotte, Giampaolo Zuccheri, Barbara Monti 2024-01-01 NEUROLOGY INTERNATIONAL - 4.02 Riassunto (Abstract) -
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model. Philipp Spatz, Sophie A M Steinmüller , Anna Tutov , Eleonora Poeta , Axelle Morilleau , Allison ...Carles , Marie H Deventer , Julian Hofmann , Christophe P Stove , Barbara Monti , Tangui Maurice , Michael Decker 2023-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista 2023 - Spatz et al JMC.pdf
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS Michele Protti, Marco Cirrincione, Sarah Palano, Eleonora Poeta, Giorgia Babini, Maria Chiara Mag...nifico, Simona Nicole Barile, Nicola Balboni, Francesca Massenzio, Mohammadreza Mahdavijalal, Federico M. Giorgi, Roberto Mandrioli, Francesco M. Lasorsa, Barbara Monti, Laura Mercolini 2023-01-01 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS - 1.01 Articolo in rivista _metabolic profile brain cells JPBA 2023.pdf
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease Gandini, Annachiara; Gonçalves, Ana Elisa; Strocchi, Silvia; Albertini, Claudia; Janočková, Jana;... Tramarin, Anna; Grifoni, Daniela; Poeta, Eleonora; Soukup, Ondrej; Muñoz-Torrero, Diego; Monti, Barbara; Sabaté, Raimon; Bartolini, Manuela; Legname, Giuseppe; Bolognesi, Maria Laura 2022-01-01 ACS CHEMICAL NEUROSCIENCE - 1.01 Articolo in rivista acschemneuro.2c00357.pdfcn2c00357_si_001.pdf
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency Poeta E.; Petralla S.; Babini G.; Renzi B.; Celauro L.; Magnifico M.C.; Barile S.N.; Masotti M.; ...De Chirico F.; Massenzio F.; Viggiano L.; Palmieri L.; Virgili M.; Lasorsa F.M.; Monti B. 2022-01-01 FRONTIERS IN CELLULAR NEUROSCIENCE - 1.01 Articolo in rivista fncel-15-773709.pdf
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors Francesca De Chirico, Eleonora Poeta, Giorgia Babini, Iliana Piccolino, Barbara Monti, Francesca ...Massenzio* 2022-01-01 FRONTIERS IN CELLULAR NEUROSCIENCE - 1.01 Articolo in rivista fncel-16-1038721.pdf
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleon...ora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti 2021-01-01 BIOMOLECULES - 1.01 Articolo in rivista biomolecules-11-00306-v2.pdf
Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model He F.; Chou C.J.; Scheiner M.; Poeta E.; Yuan Chen N.; Gunesch S.; Hoffmann M.; Sotriffer C.; Mon...ti B.; Maurice T.; Decker M. 2021-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista Melatonin- and Ferulic Acid-Based HDAC6.docx
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M. 2021-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profi...lo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B. 2019-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-20-04486.pdf
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M....; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M. 2019-01-01 JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista dual acting_am_ 730794.pdf
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Pet...ralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G. 2019-01-01 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - 1.01 Articolo in rivista -